Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Kidney Research and Clinical Practice
|
February 16, 2016
Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet
Hye Sook Min, Jung Eun Kim, Mi Hwa Lee, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 26, 2016
A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney Research and Clinical Practice
|
April 11, 2017
Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: <i>post-hoc</i> analysis of the Kremezin Study against renal disease progression in Korea
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney Research and Clinical Practice
|
April 10, 2018
Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: <i>post-hoc</i> analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78]
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney International
|
December 22, 2004
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
Nan Hee Kim, Jeong Heon Oh, Ji A Seo, et al.
Plos One
|
May 3, 2013
Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice
Jung Eun Kim, Mi Hwa Lee, Deok Hwa Nam, et al.
Kidney International
|
August 6, 2010
CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice
Young Sun Kang, Mi Hwa Lee, Hye Kyoung Song, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 2, 2014
Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction
Hye Sook Min, Jung Eun Kim, Mi Hwa Lee, et al.
Cell Transplantation
|
April 25, 2012
Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy
Young Youl Hyun, In Ok Kim, Mi Hyung Kim, et al.
The Korean Journal of Internal Medicine
|
November 28, 2017
Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease
Seon Ha Baek, Ran-Hui Cha, Shin Wook Kang, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Kidney Research and Clinical Practice
|
February 16, 2016
Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet
Hye Sook Min, Jung Eun Kim, Mi Hwa Lee, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 26, 2016
A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney Research and Clinical Practice
|
April 11, 2017
Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: <i>post-hoc</i> analysis of the Kremezin Study against renal disease progression in Korea
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney Research and Clinical Practice
|
April 10, 2018
Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: <i>post-hoc</i> analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78]
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney International
|
December 22, 2004
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
Nan Hee Kim, Jeong Heon Oh, Ji A Seo, et al.
Plos One
|
May 3, 2013
Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice
Jung Eun Kim, Mi Hwa Lee, Deok Hwa Nam, et al.
Kidney International
|
August 6, 2010
CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice
Young Sun Kang, Mi Hwa Lee, Hye Kyoung Song, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 2, 2014
Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction
Hye Sook Min, Jung Eun Kim, Mi Hwa Lee, et al.
Cell Transplantation
|
April 25, 2012
Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy
Young Youl Hyun, In Ok Kim, Mi Hyung Kim, et al.
The Korean Journal of Internal Medicine
|
November 28, 2017
Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease
Seon Ha Baek, Ran-Hui Cha, Shin Wook Kang, et al.
Page
of 9